NCS Multistage (NCSM) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
17 Jan, 2026Executive summary
Q3 2024 revenue reached $44.0 million, up 15% year-over-year, with growth across U.S., Canada, and international markets; net income was $4.1 million ($1.60 per diluted share).
For the first nine months of 2024, revenue was $117.6 million–$118 million (+10% YoY), with net income of $3.1 million ($1.21 per diluted share).
International revenue for the first nine months was $12 million, up 124% YoY, already surpassing full-year 2023 and comprising 10% of total revenue.
Business optimization and cost-saving initiatives from 2023 continue to benefit 2024 results, with SG&A expenses for the first nine months lower than the prior year.
The company operates as a single reportable segment, focusing on engineered products and services for oil and gas well construction and completions.
Financial highlights
Q3 2024 adjusted gross margin was 42%, up from 41% in Q3 2023; adjusted EBITDA was $7.1 million (+$0.3 million YoY), margin at 16%.
Q3 2024 product sales were $31.7 million (+16.1% YoY); services revenue was $12.3 million (+12.2%).
Cash and cash equivalents at September 30, 2024 were $15.3 million; total debt was $8.6 million, all finance leases.
Free cash flow less distributions to non-controlling interest for the first nine months was $0.4 million, up $3.3 million YoY.
Net working capital at September 30, 2024 was $64.1 million, up from $56.3 million at year-end 2023.
Outlook and guidance
Q4 2024 revenue expected between $38 million–$42 million; adjusted gross margin 40%–42%; adjusted EBITDA: $4.0–$6.5 million.
Full-year 2024 revenue guidance raised to $155.5 million–$159.5 million (+11% YoY at midpoint); adjusted EBITDA guidance increased to $18 million–$20.5 million (+49% YoY at midpoint).
2024 free cash flow expected at $6 million–$10 million; year-end cash position projected to exceed $20 million.
Management expects Q4 revenue to decline sequentially 5–15% due to seasonality but remain above prior year.
Capital expenditures for 2024 expected at $1.2–$1.7 million, focused on equipment upgrades and technology.
Latest events from NCS Multistage
- 2025 delivered double-digit revenue and EBITDA growth, with 2026 guidance projecting further gains.NCSM
Q4 20256 Mar 2026 - Q2 2024 revenue up 17% with improved margins and raised 2024 guidance on strong international growth.NCSM
Q2 20242 Feb 2026 - Strong 2024 growth, innovation, and international expansion drive robust margins and free cash flow.NCSM
Emerging Growth Virtual Conference27 Dec 2025 - Record international growth, margin expansion, and strong cash position highlight 2024 results.NCSM
Q4 202425 Dec 2025 - Q1 revenue and profit surged on Canadian and international strength, with margins expanding.NCSM
Q1 202524 Dec 2025 - Up to $200M in common stock registered for sale, supporting growth amid oilfield sector risks.NCSM
Registration Filing16 Dec 2025 - Strong international growth, margin expansion, and strategic acquisitions drive robust free cash flow.NCSM
Sidoti's Year End Virtual Investor Conference12 Dec 2025 - Stockholders will vote on directors, auditor, executive pay, and an expanded equity plan.NCSM
Proxy Filing1 Dec 2025 - Key votes include director elections, auditor ratification, and executive pay approval.NCSM
Proxy Filing1 Dec 2025